CompletedNot Applicable

Assessing the Effects of Patient Self-Rating of Voice Quality on Voice Therapy Attendance and Outcomes

United States42 participantsStarted 2023-01-19

Plain-language summary

The purpose of this study is to assess the effects of incorporating educational online modules into voice therapy. One of the main reasons that voice therapy fails is lack of participation and engagement from the patient's side. The researchers hope to learn if increasing patient engagement via educational online modules during this waiting period between evaluation and first therapy session is useful in increasing understanding of the therapeutic framework of voice therapy.

Who can participate

Age range

18 Years – 100 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>18 years * English-speaking * Have access to technology, including Internet * Diagnosed with dysphonia with a recommended treatment of voice therapy. * Willingness to complete all clinical/research assessments * Ability to give informed consent Exclusion Criteria: * Patients who undergo surgical intervention during the course of therapy Contraindications for participation in voice therapy * Diagnosis of Parkinson's Disease or other neurodegenerative, progressive disorder (e.g., ALS) * Previous training in acoustic-perceptual voice quality rating, for example a speech language pathology student * Visual impairments that would prevent the completion of an online module. * Those with self-reported moderate-profound hearing loss or deafness that would preclude them from participating in the study * Inability to give informed consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change of voice handicap perception across the 3 groups

Timeframe: Baseline (Day 1) visit, 8 - 10 week visit

Change of Online education module acceptance across the 3 groups

Timeframe: Baseline Visit (Day 1), Last day of visit (up to 4 months from baseline)

Trial details

NCT IDNCT05237648

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-22

View on ClinicalTrials.gov More Dysphonia trials